74447-40-8

Usage

Uses

Used in Fragrance and Flavor Industry:
4-(2,2-DIMETHOXY-ETHYL)-PHENOL is used as a fragrance ingredient for its pleasant, aromatic odor, making it suitable for incorporation into perfumes and personal care products.
Used in Pharmaceutical Industry:
4-(2,2-DIMETHOXY-ETHYL)-PHENOL is used as a chemical intermediate in the synthesis of pharmaceuticals, contributing to the development of various medicinal compounds.
Used in Organic Synthesis:
4-(2,2-DIMETHOXY-ETHYL)-PHENOL is utilized as a key component in the synthesis of other organic compounds, highlighting its importance in organic chemistry.
Used in Antioxidant Applications:
4-(2,2-DIMETHOXY-ETHYL)-PHENOL is studied for its potential antioxidant properties, which could be harnessed to protect against oxidative stress and related conditions in various applications.
Used in Antimicrobial Applications:
4-(2,2-DIMETHOXY-ETHYL)-PHENOL has been investigated for its antibacterial properties, suggesting its possible use in applications requiring microbial control or preservation.

Upstream product

• 74447-41-9 2-(4-benzyloxyphenyl)-1,1-dimethoxyethane 
• 836-43-1 4-benzyloxybenzyl alcohol 
• 74447-42-0 2-(4-benzyloxybenzyl)-1,3-dithian 
• 836-42-0 4-benzyloxybenzyl chloride 

Downstream Products

• 501-94-0 p-hydroxyphenethyl alcohol 
• 74447-32-8 O,O-dibenzoyltyrosol 
• 74447-38-4 4-(2-hydroxyethyl)phenyl methanesulfonate 
• 74447-37-3 4-methylsulphonyloxyphenylacetaldehyde 
• 74447-36-2 1-(Methylsulfonyloxy)-2-[4-(methylsulfonyloxy)phenyl]ethane 
• 74447-52-2 (1R)-2-(4-methylsulphonyloxyphenyl)<1-(2)H1>ethanol 
• 74447-54-4 (1R)-2-(4-methoxysulphonyloxyphenyl)<1-(3)H1>ethanol 
• 173592-83-1 4-((2,2-dimethoxy)ethyl)-1-((2E)-2-methyl-7-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2-heptenyloxy)benzene 
• 74447-39-5 1,1-dimethoxy-2-(4-methylsulphonyloxyphenyl)ethane 

Relevant academic research and scientific papers

4-ARYL- AND 4-ARYLTHIO-5-HYDROXY-2(5H)-FURANONES AS INHIBITORS OF PHOSPHOLIPASE A2

The invention provides novel 5-hydroxy-4-aryl- and 5-hy-droxy-4-(arylthio)-2(5H)-furanones of the following structure: wherein R contains from about five to about twenty carbon atoms and is defined herein; X is oxygen, sulfur, S02, NH, N(lower alkyl), N(lower acyl), aminocarbonyl, carbonyl, carbonylamino, CH2 or a carbon-carbon bond; Y is hydrogen, halogen, lower alkyl, nitro, alkylthio, perfluoroalkyl, hydroxy, or lower alkoxy(C1-C8); Z is sulfur or a carbon-carbon bond; and Q is H, an alkyl of from 1-20 carbon atoms, COR', COOR', CONHR', PO(OR')2, PO(OR')R" wherein R' and R" are independently selected from the group consisting of H, an alkyl of from 1-20 carbon atoms, phenyl, and substituted phenyl and prodrugs thereof and pharmaceutically acceptable salts thereof. Pharmaceutical compositions comprising these compounds, methods of using these compounds as inhibitors of inflammation and for treating other diseases characterized by the overproduction of arachidonic acid metabolites, intermediates and methods of preparing these compounds are also provided.